Cardinal Health, Inc. $CAH Stock Position Cut by Clifford Capital Partners LLC

Clifford Capital Partners LLC cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,717 shares of the company’s stock after selling 21,329 shares during the period. Cardinal Health comprises about 3.9% of Clifford Capital Partners LLC’s portfolio, making the stock its 6th biggest position. Clifford Capital Partners LLC’s holdings in Cardinal Health were worth $23,163,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Redhawk Wealth Advisors Inc. increased its stake in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after purchasing an additional 48 shares during the period. HF Advisory Group LLC grew its position in shares of Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after buying an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. grew its position in shares of Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after buying an additional 50 shares in the last quarter. Generali Asset Management SPA SGR grew its position in shares of Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock worth $105,000 after buying an additional 51 shares in the last quarter. Finally, Stephens Inc. AR grew its position in shares of Cardinal Health by 0.9% during the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after buying an additional 52 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.6%

CAH stock opened at $226.29 on Thursday. The company has a market capitalization of $53.00 billion, a P/E ratio of 34.60, a PEG ratio of 1.25 and a beta of 0.52. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The business has a 50 day simple moving average of $204.01 and a 200-day simple moving average of $209.11.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of analyst reports. TD Cowen boosted their price objective on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. William Blair began coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. lowered their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Finally, Barclays upped their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.